Author:
Naini Al Arofatus,Mayanti Tri,Hilmayanti Erina,Huang Xuhao,Kabayama Kazuya,Shimoyama Atsushi,Manabe Yoshiyuki,Fukase Koichi,Supratman Unang
Abstract
AbstractIn recent decades, the interest in natural products with immunomodulatory properties has increased due to their therapeutic potential. These products have a wider range of pharmacological activities and demonstrate lower toxicity levels when compared to their synthetic counterparts. Therefore, this study aimed to investigate the immunomodulatory effects of sesquiterpenoids (SQs) and sesquiterpenoid dimers (SQDs) isolated from Dysoxylum parasiticum (Osbeck) Kosterm. stem bark on human and murine cells, particularly focusing on toll-like receptor 4 (TLR4). Utilizing the secreted alkaline phosphatase (SEAP) assay on engineered human and murine TLR4 of HEK-Blue cells, antagonist TLR4 compounds were identified, including SQs 6, 9, and 10, as well as SQDs 17 and 22. The results showed that 10-hydroxyl-15-oxo-α-cadinol (9) had a potent ability to reduce TLR4 activation induced by LPS stimulation, with minimal toxicity observed in both human and murine cells. The SEAP assay also revealed diverse immune regulatory effects for the same ligand. For instance, SQs 12, 14, and 16 transitioned from antagonism on human to murine TLR4. The SQs (4, 7, 11, and 15) and SQDs (18–20) offered partial antagonist effect exclusively on murine TLR4. Furthermore, these selected SQs and SQDs were assessed for their influence on the production of proinflammatory cytokines TNF-α, IL-1α, IL-1β, and IL-6 of the NF-κB signaling pathway in human and murine macrophage cell lines, showing a dose-dependent manner. Additionally, a brief discussion on the structure-activity relationship was presented.
Funder
University of Padjadjaran
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Perera, N. et al. Carboxylic and O-acetyl moieties are essential for the immunostimulatory activity of glucuronoxylomannan: A novel TLR4 specific immunostimulator from Auricularia auricula-judae. Chem. Comm. 54, 6995–6998 (2018).
2. Corthay, A. Does the immune system naturally protect against cancer?. Front. Immunol. 5, 197 (2014).
3. Harun, N. H., Septama, A. W., Ahmad, W. A. N. W. & Suppia, R. Immunomodulatory effects and structure-activity relationship of botanical pentacyclic triterpenes: A review. Chin. Herb. Med. 12, 118–124 (2020).
4. Bascones-Martinez, A., Mattila, R., Gomez-Font, R. & Meurman, J. H. Immunomodulatory drugs: Oral and systemic adverse effects. Med. Oral Patol. Oral Cir. Bucal 19, 24 (2014).
5. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).